- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about VXRT
Recent news which mentions VXRT
Don’t Write Off Vaxart, As Its Oral Vaccine Still Has a Chance
October 20, 2021
Tickers
VXRT
From InvestorPlace
NVAX Stock: The Huge Reason Novavax Is Plunging Today
October 20, 2021
From InvestorPlace
Can This COVID Vaccine Stock Help Make You Rich?
October 16, 2021
From Motley Fool
From Benzinga
Vaxart May Be a COVID Vaccine Game Changer -- but Is It Too Late?
October 10, 2021
From Motley Fool
18 Stocks Moving in Friday's Pre-Market Session
October 08, 2021
From Benzinga
These 2 COVID-19 Stocks Could Boost the Market Friday
October 07, 2021
From Motley Fool
Why Vaxart Shares Are Surging In Thursday's After-Hours Session
October 07, 2021
Tickers
VXRT
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
October 07, 2021
From Benzinga
Vaxart Starts Recruitment In Mid-Stage COVID-19 Oral Vaccine Trial
October 06, 2021
Tickers
VXRT
From Benzinga
Why Investing in VXRT Stock is a Coin Flip
October 06, 2021
From InvestorPlace
From InvestorPlace
Why Pfizer, BioNTech, Novavax, and Vaxart Stocks Are Sinking Today
October 01, 2021
From Motley Fool
4 Stocks Expected to Increase Sales 25,750% to 2,970,000% in 5 Years
September 30, 2021
From Motley Fool
Vaxart Traders Should Not Dismiss the Vaccine Maker’s Momentum
September 27, 2021
Tickers
VXRT
From InvestorPlace
It’s Time to Start Thinking Seriously About Vaxart
September 22, 2021
Tickers
VXRT
From InvestorPlace
4 Small-Cap Growth Stocks Expected to Increase Sales 707% to 9,406% by 2024
September 16, 2021
From Motley Fool
Here's Some Good News for Vaccine Stock Investors
September 14, 2021
From Motley Fool
Vaxart Looks To Be On The Verge Of Breaking Out Of A Pattern
September 13, 2021
Tickers
VXRT
From Benzinga
Vaxart Stock Is One Vaccine Also-Ran Worth Another Look
September 08, 2021
From InvestorPlace
5 Reasons Moderna May Prove Wall Street Wrong
September 05, 2021
From Motley Fool
Longshot Covid Play Vaxart Stock Is Too Risky at These Prices
August 27, 2021
From InvestorPlace
Vaxart Is Another Risky Biotech Stock to Avoid Right Now
August 17, 2021
Tickers
VXRT
From InvestorPlace
7 Biotech Stocks to Buy Amid the Delta Variant’s Onslaught
August 11, 2021
From InvestorPlace
The Delta Variant Is a Shot in the Arm for Vaxart’s Pill Vaccine
August 10, 2021
Tickers
VXRT
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.